{"id":"aspirin-and-or-atorvastatin","safety":{"commonSideEffects":[{"rate":"1-3","effect":"Gastrointestinal bleeding or ulceration (aspirin)"},{"rate":"2-5","effect":"Muscle pain or myalgia (atorvastatin)"},{"rate":"1-3","effect":"Elevated liver enzymes (atorvastatin)"},{"rate":"5-10","effect":"Dyspepsia"},{"rate":"<0.1","effect":"Rhabdomyolysis (rare)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Aspirin irreversibly inhibits cyclooxygenase (COX), preventing thromboxane A2 synthesis and platelet aggregation, thereby reducing thrombotic events. Atorvastatin competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, lowering LDL cholesterol and reducing atherosclerotic plaque formation. This combination addresses both thrombotic and lipid-related mechanisms of cardiovascular disease.","oneSentence":"Aspirin inhibits platelet aggregation via COX inhibition, while atorvastatin reduces cholesterol synthesis by inhibiting HMG-CoA reductase, together reducing cardiovascular risk.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:42:45.848Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Secondary prevention of cardiovascular events (myocardial infarction, stroke)"},{"name":"Primary prevention of cardiovascular disease in high-risk patients"}]},"trialDetails":[{"nctId":"NCT06308952","phase":"PHASE4","title":"Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation","status":"RECRUITING","sponsor":"Duan Chuanzhi","startDate":"2024-07-30","conditions":"Cerebrovascular Event, Stent Stenosis, Ischemic Stroke","enrollment":354},{"nctId":"NCT03417388","phase":"PHASE4","title":"Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2018-02-09","conditions":"Coronary Artery Disease","enrollment":2476},{"nctId":"NCT06930885","phase":"PHASE3","title":"Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease","status":"RECRUITING","sponsor":"Hospital do Coracao","startDate":"2025-06-12","conditions":"Atherothrombotic Diseases, Atherosclerotic Cardiovascular Disease (ASCVD)","enrollment":7713},{"nctId":"NCT07012629","phase":"PHASE3","title":"A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)","status":"RECRUITING","sponsor":"Aarhus University Hospital","startDate":"2025-11-26","conditions":"Covert Brain Infarction","enrollment":1652},{"nctId":"NCT06336174","phase":"","title":"Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study","status":"RECRUITING","sponsor":"Anhui Medical University","startDate":"2022-11-01","conditions":"Intracranial Atherosclerosis, Cognitive Impairment, Cerebrovascular Event","enrollment":100},{"nctId":"NCT07121088","phase":"PHASE4","title":"Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study","status":"NOT_YET_RECRUITING","sponsor":"Guangzhou University of Traditional Chinese Medicine","startDate":"2025-08-31","conditions":"Ischemic Cerebral Infarction, Diabetes Mellitus","enrollment":3666},{"nctId":"NCT04379999","phase":"EARLY_PHASE1","title":"Atorvastatin ± Aspirin in Lynch Syndrome Syndrome","status":"COMPLETED","sponsor":"Fox Chase Cancer Center","startDate":"2018-09-10","conditions":"Lynch Syndrome","enrollment":43},{"nctId":"NCT02596126","phase":"PHASE3","title":"Secondary Prevention of Cardiovascular Disease in the Elderly Trial","status":"COMPLETED","sponsor":"Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III","startDate":"2016-07","conditions":"Myocardial Infarction, Cardiovascular Disease","enrollment":2499},{"nctId":"NCT04824911","phase":"PHASE2","title":"Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Disease","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2021-03-23","conditions":"Acute Stroke, Dual Antiplatelet Therapy, Statin","enrollment":376},{"nctId":"NCT05122780","phase":"PHASE4","title":"Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-07-01","conditions":"Myocardial Infarction With Non-Obstructive Coronary Arteries","enrollment":120},{"nctId":"NCT05479097","phase":"NA","title":"Feasibility Study of a Novel mHealth Application to Enable Community Health Workers to Manage","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2023-02-06","conditions":"Hypertension","enrollment":32},{"nctId":"NCT04181749","phase":"PHASE2","title":"Peri-vascular Adipose Tissue Inflammation Evaluated Using Coronary CT Angiography","status":"UNKNOWN","sponsor":"University of Leicester","startDate":"2020-11-18","conditions":"Cardiovascular Risk Factor","enrollment":200},{"nctId":"NCT06112028","phase":"PHASE4","title":"Clinical Study of Tongxinluo Capsule in Preventing and Treating Restenosis After Intracranial and External Arterial Stenting","status":"NOT_YET_RECRUITING","sponsor":"Yanbin Li","startDate":"2023-10","conditions":"Stent Restenosis","enrollment":200},{"nctId":"NCT03635749","phase":"PHASE3","title":"Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis","status":"UNKNOWN","sponsor":"Beijing Tiantan Hospital","startDate":"2018-09-17","conditions":"Acute Stroke, Transient Ischemic Attack","enrollment":6100},{"nctId":"NCT03703635","phase":"NA","title":"Balloon Angioplasty for Symptomatic Intracranial Artery Stenosis","status":"UNKNOWN","sponsor":"Ministry of Science and Technology of the People´s Republic of China","startDate":"2018-10-17","conditions":"Intracranial Artery Stenosis","enrollment":512},{"nctId":"NCT05565976","phase":"PHASE2, PHASE3","title":"Dapagliflozin Effect in Cognitive Impairment in Stroke Trial","status":"UNKNOWN","sponsor":"Jaime Daniel Mondragon","startDate":"2020-08-01","conditions":"Stroke, Ischemic, Mild Cognitive Impairment, Dementia, Vascular","enrollment":270},{"nctId":"NCT03820466","phase":"PHASE3","title":"Effect of Platelet Inhibition and / or Lipid Lowering in Non-ACS-patients With Positive Troponin","status":"TERMINATED","sponsor":"Dr. med. Mahir Karakas","startDate":"2020-02-21","conditions":"Acute Chest Syndrome","enrollment":68},{"nctId":"NCT00231803","phase":"NA","title":"The Canadian Prevention of Renal and Cardiovascular Endpoints Trial","status":"COMPLETED","sponsor":"Brendan Barrett","startDate":"2005-04","conditions":"Chronic Kidney Disease","enrollment":474},{"nctId":"NCT04581759","phase":"NA","title":"Endovascular Treatment and RIPC in Acute Ischemic Stroke","status":"UNKNOWN","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2021-04-12","conditions":"Acute Ischemic Stroke, Endovascular Treatment","enrollment":300},{"nctId":"NCT03228017","phase":"PHASE4","title":"Subclinical Cardiovascular Disease in Psoriatic Disease","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2017-08-01","conditions":"Cardiovascular Diseases, Myocardial Infarction, Atherosclerotic Cardiovascular Disease","enrollment":63},{"nctId":"NCT04850001","phase":"","title":"Cognitive Decline in Asymptomatic Intracranial Stenosis Patients: A 1-Year Follow-Up Study","status":"UNKNOWN","sponsor":"Anhui Medical University","startDate":"2020-09-10","conditions":"Magnetic Resonance Imaging, Asymptomatic Intracranial Stenosis, Medical Treatment","enrollment":40},{"nctId":"NCT04744571","phase":"NA","title":"Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Total Occlusions","status":"UNKNOWN","sponsor":"Beijing Anzhen Hospital","startDate":"2021-02","conditions":"Coronary Artery Disease, Coronary Occlusion, Percutaneous Coronary Intervention","enrollment":200},{"nctId":"NCT04661709","phase":"PHASE4","title":"Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris","status":"UNKNOWN","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2021-03-01","conditions":"Coronary Heart Disease, Unstable Angina, Chinese Herbal Medicine","enrollment":502},{"nctId":"NCT04087382","phase":"NA","title":"Mechanical Thrombectomy in Acute Ischemic Stroke Beyond the Time of Window","status":"COMPLETED","sponsor":"Assiut University","startDate":"2019-01-15","conditions":"Acute Ischemic Stroke","enrollment":57},{"nctId":"NCT03372785","phase":"","title":"The Success of Opening Concurrent CTO leSion to Improve Cardiac Function Trial in Patients With Multi-vessel Disease","status":"UNKNOWN","sponsor":"Beijing Anzhen Hospital","startDate":"2018-04-10","conditions":"Chronic Total Occlusion of Coronary Artery, Percutaneous Coronary Intervention, Coronary Artery Disease","enrollment":240},{"nctId":"NCT04434365","phase":"PHASE1, PHASE2","title":"Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2019-06-21","conditions":"Stable Coronary Artery Disease, Percutaneous Coronary Intervention","enrollment":24},{"nctId":"NCT04425590","phase":"PHASE2, PHASE3","title":"The Benefit of Add On DLBS1033 for Ischemic Stroke Patient","status":"UNKNOWN","sponsor":"Duta Wacana Christian University","startDate":"2020-04-01","conditions":"Ischemic Stroke","enrollment":180},{"nctId":"NCT00687076","phase":"PHASE4","title":"Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2004-04","conditions":"Peripheral Arterial Disease","enrollment":102},{"nctId":"NCT03370705","phase":"PHASE3","title":"Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT Alone","status":"UNKNOWN","sponsor":"Alfa Wassermann Tunisia","startDate":"2019-01-31","conditions":"Peripheral Arterial Obstructive Disease","enrollment":156},{"nctId":"NCT04091412","phase":"PHASE4","title":"Study of Collateral Circulation in Patients With Symptomatic Intracranial Anterior Circulation Occlusion","status":"UNKNOWN","sponsor":"The Second Hospital of Hebei Medical University","startDate":"2019-05-05","conditions":"Collateral Circulation, Large-artery Occlusion, Cerebral Infarction","enrollment":500},{"nctId":"NCT02767401","phase":"PHASE4","title":"The Success of Opening Single CTO Lesions to Improve Myocardial Viability Study (SOS-comedy)","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Dalian Medical University","startDate":"2015-09-15","conditions":"Hibernation, Myocardial, Complete Occlusion of Coronary Artery","enrollment":200},{"nctId":"NCT01271985","phase":"PHASE3","title":"Prevention of Cardiovascular Disease in Middle-aged and Elderly Iranians Using a Single PolyPill","status":"COMPLETED","sponsor":"Tehran University of Medical Sciences","startDate":"2011-02","conditions":"Cardiovascular Diseases","enrollment":8410},{"nctId":"NCT02539810","phase":"PHASE4","title":"Renal Artery Stenting in Patients With Documented Resistant Hypertension and Atherosclerotic Renal Artery Stenosis (ANDORRA)","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-09","conditions":"Hypertension, Hypertension Resistant to Conventional Therapy, Angiographically Proven Grade III Unilateral or Bilateral Atherosclerotic Renal Artery Stenosis (ARAS) Greater Than or Equal to 60 Percent","enrollment":4},{"nctId":"NCT02219191","phase":"NA","title":"Puerarin Versus Atorvastatin in Treating Metabolism Syndrome in Patients With Chronic Rheumatic Diseases","status":"UNKNOWN","sponsor":"Chengdu PLA General Hospital","startDate":"2014-08","conditions":"Rheumatoid Arthritis","enrollment":150},{"nctId":"NCT01318564","phase":"","title":"Diabetic Treatment Adherence","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2011-03","conditions":"Endocrine System Diseases","enrollment":28},{"nctId":"NCT02800174","phase":"NA","title":"Smart Nitinol Stent System for the Treatment of Severe Atherosclerotic Carotid Stenosis","status":"COMPLETED","sponsor":"Beijing Jishuitan Hospital","startDate":"2006-06","conditions":"Carotid Artery Stenosis","enrollment":103},{"nctId":"NCT01322711","phase":"PHASE4","title":"Atorvastatin, Aspirin, Oxidative Stress, Coagulation and Platelet Activation Indexes","status":"UNKNOWN","sponsor":"University of Roma La Sapienza","startDate":"2011-03","conditions":"Type 2 Diabetes Mellitus, Hypercholesterolemia","enrollment":60},{"nctId":"NCT02357212","phase":"NA","title":"Early Invasive Versus Conservative Therapy in Women With an Acute Coronary Syndrome","status":"COMPLETED","sponsor":"University of Florida","startDate":"2009-04","conditions":"Acute Coronary Syndrome","enrollment":40},{"nctId":"NCT01974544","phase":"NA","title":"Prevention and Treatment Of Diabetes Complications With Gastric Surgery or Intensive Medicines","status":"UNKNOWN","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2013-05","conditions":"Type 2 Diabetes","enrollment":150},{"nctId":"NCT00065806","phase":"PHASE3","title":"Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE)","status":"COMPLETED","sponsor":"Laura Schanberg","startDate":"2003-09","conditions":"Lupus Erythematosus, Systemic","enrollment":221},{"nctId":"NCT01665235","phase":"NA","title":"Blood Pressure Variability and the Prognosis of Ischemic Stroke With Intracranial Artery Stenosis","status":"UNKNOWN","sponsor":"RenJi Hospital","startDate":"2012-08","conditions":"Blood Pressure Variability, Intracranial Artery Stenosis","enrollment":200},{"nctId":"NCT01502943","phase":"PHASE4","title":"Studies of Traditional Chinese Medicine Clinical Efficacy Evaluation Index","status":"COMPLETED","sponsor":"Liaoning University of Traditional Chinese Medicine","startDate":"2011-05","conditions":"Coronary Heart Disease, Stable Angina Pectoris","enrollment":480},{"nctId":"NCT00691314","phase":"NA","title":"Efficacy and Safety of Stent Implantation in Symptomatic Extra- and Intracranial Artery Stenosis","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2008-06","conditions":"Stroke, Transient Ischemic Attack, Atherosclerosis","enrollment":300},{"nctId":"NCT00734123","phase":"PHASE4","title":"Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases.","status":"UNKNOWN","sponsor":"Hospital Arnau de Vilanova","startDate":"2008-04","conditions":"Atherosclerosis, Cardiovascular Diseases","enrollment":2948}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":90662,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Aspirin and/or Atorvastatin","genericName":"Aspirin and/or Atorvastatin","companyName":"NYU Langone Health","companyId":"nyu-langone-health","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Aspirin inhibits platelet aggregation via COX inhibition, while atorvastatin reduces cholesterol synthesis by inhibiting HMG-CoA reductase, together reducing cardiovascular risk. Used for Secondary prevention of cardiovascular events (myocardial infarction, stroke), Primary prevention of cardiovascular disease in high-risk patients.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}